News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ferra Joseph J Jr
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Ferra Joseph J Jr (INTERIM CEO & CFO) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Granted 240,000 options to buy
@ $0.75, valued at
$180k
Granted 30,000 options to buy
@ $0.75, valued at
$22.5k
|
|
| 12/19/2022 |
4
| Ferra Joseph J Jr (CFO) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Paid exercise price by delivering 19,095 shares
@ $1.26, valued at
$24.1k
Paid exercise price by delivering 4,773 shares
@ $1.25, valued at
$6k
Paid exercise price by delivering 4,773 shares
@ $0.95, valued at
$4.5k
Exercised 50,249 restricted stock units
@ $0
Exercised 12,562 restricted stock units
@ $0
Exercised 12,562 restricted stock units
@ $0 |
|
| 02/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Ferra Joseph J Jr (CFO) has filed a Form 4 on Elevation Oncology, Inc.|
Txns:
| Granted 249,104 options to buy
@ $16, valued at
$4M
Granted 200,995 restricted stock units
@ $0 |
|
| 06/24/2021 |
3
| Ferra Joseph J Jr (CFO) has filed a Form 3 on Elevation Oncology, Inc. |
| 02/19/2021 |
4
| Ferra Joseph J Jr (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 119,000 options to buy
@ $11.41, valued at
$1.4M
|
|
| 02/14/2020 |
4
| Ferra Joseph J Jr (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 94,000 options to buy
@ $7.54, valued at
$708.8k
|
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2018 |
4
| Ferra Joseph J Jr (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $12.32, valued at
$1.8M
Granted 50,000 options to buy
@ $12.32, valued at
$616k
|
|
| 03/12/2018 |
3
| Ferra Joseph J Jr (CFO) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
|
|